Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP).

Mutations in the PEX gene at Xp22.1 (phosphate-regulating gene with homologies to endopeptidases, on the X-chromosome), are responsible for X-linked hypophosphataemic rickets (HYP). Homology of PEX to the M13 family of Zn2+ metallopeptidases which include neprilysin (NEP) as prototype, has raised important questions regarding PEX function at the molecular level. The aim of this study was to analyse 99 HYP families for PEX gene mutations, and to correlate predicted changes in the protein structure with Zn2+ metallopeptidase gene function. Primers flanking 22 characterised exons were used to amplify DNA by PCR, and SSCP was then used to screen for mutations. Deletions, insertions, nonsense mutations, stop codons and splice mutations occurred in 83% of families screened for in all 22 exons, and 51% of a separate set of families screened in 17 PEX gene exons. Missense mutations in four regions of the gene were informative regarding function, with one mutation in the Zn2+-binding site predicted to alter substrate enzyme interaction and catalysis. Computer analysis of the remaining mutations predicted changes in secondary structure, N-glycosylation, protein phosphorylation and catalytic site molecular structure. The wide range of mutations that align with regions required for protease activity in NEP suggests that PEX also functions as a protease, and may act by processing factor(s) involved in bone mineral metabolism.

[1]  P. Rowe,et al.  The PEX gene: its role in X-linked rickets, osteomalacia, and bone mineral metabolism. , 1997, Experimental nephrology.

[2]  F. Glorieux,et al.  cDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone. , 1996, Genomics.

[3]  A. Ong,et al.  Candidate 56 and 58 kDa protein(s) responsible for mediating the renal defects in oncogenic hypophosphatemic osteomalacia. , 1996, Bone.

[4]  M. Econs,et al.  Phosphate transport in immortalized cell cultures from the renal proximal tubule of normal and Hyp Mice: Evidence That the HYP gene locus product is an extrarenal factor , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  A. Poustka,et al.  A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets , 1995, Nature Genetics.

[6]  F. Glorieux,et al.  Effect of 1,25‐dihydroxyvitamin D3 treatment on bone formation by transplanted cells from normal and X‐linked hypophosphatemic mice , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  R. Browne,et al.  The effect of phosphate supplementation on linear growth in children with X-linked hypophosphatemia. , 1994, Pediatrics.

[8]  J. Chan,et al.  X-linked hypophosphatemia: molecular biology and treatment controversies. , 1994, Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui.

[9]  M. Econs,et al.  Tumor-induced osteomalacia--unveiling a new hormone. , 1994, The New England journal of medicine.

[10]  P. Kao,et al.  Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia. , 1994, The New England journal of medicine.

[11]  E. Fisher,et al.  Human haploinsufficiency — one for sorrow, two for joy , 1994, Nature Genetics.

[12]  S. Roy,et al.  Increased renal 25-hydroxyvitamin D3-24-hydroxylase messenger ribonucleic acid and immunoreactive protein in phosphate-deprived Hyp mice: a mechanism for accelerated 1,25-dihydroxyvitamin D3 catabolism in X-linked hypophosphatemic rickets. , 1994, Endocrinology.

[13]  A. Werner,et al.  Renal Na(+)-phosphate cotransport in murine X-linked hypophosphatemic rickets. Molecular characterization. , 1994, The Journal of clinical investigation.

[14]  C. Scriver,et al.  Parental origin of mutant allele does not explain absence of gene dose in X-linked Hyp mice. , 1993, Genetical research.

[15]  H. Armbrecht,et al.  Effects of 1,25-dihydroxyvitamin D3 and phorbol ester on 25-hydroxyvitamin D3 24-hydroxylase cytochrome P450 messenger ribonucleic acid levels in primary cultures of rat renal cells. , 1993, Endocrinology.

[16]  F. Schranck,et al.  X‐linked hypophosphatemic rickets: A study (with literature review) of linear growth response to calcitriol and phosphate therapy , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  L. Hersh,et al.  Exon 16 del: a novel form of human neutral endopeptidase (CALLA). , 1992, The American journal of physiology.

[18]  R. Griffiths,et al.  Crosstransplantation of kidneys in normal and Hyp mice. Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect. , 1992, The Journal of clinical investigation.

[19]  F. Glorieux,et al.  Effect of dietary phosphate deprivation and supplementation of recipient mice on bone formation by transplanted cells from normal and X‐linked hypophosphatemic mice , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  C. Gundberg,et al.  Development and validation of a radioimmunoassay for mouse osteocalcin: paradoxical response in the Hyp mouse. , 1992, Endocrinology.

[21]  F. Glorieux,et al.  Defective bone formation by hyp mouse bone cells transplanted into normal mice: Evidence in favor of an intrinsic osteoblast defect , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[22]  G. Semenza,et al.  Cloning and expression of cDNA for a Na/Pi cotransport system of kidney cortex. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[23]  N. Nakagawa,et al.  Characterization of the defect in the Na(+)-phosphate transporter in vitamin D-resistant hypophosphatemic mice. , 1991, The Journal of biological chemistry.

[24]  J. Schwartz,et al.  A Novel Potential Metallopeptidase Derived from the Enkephalinase Gene by Alternative Splicing , 1990, Journal of neurochemistry.

[25]  A. Boneh,et al.  Evidence for protein kinase C involvement in the regulation of renal 25-hydroxyvitamin D3-24-hydroxylase. , 1990, Endocrinology.

[26]  H. Tenenhouse,et al.  Abnormal regulation of renal vitamin D catabolism by dietary phosphate in murine X-linked hypophosphatemic rickets. , 1990, The Journal of clinical investigation.

[27]  A. Boneh,et al.  Phorbol myristate acetate activates protein kinase C, stimulates the phosphorylation of endogenous proteins and inhibits phosphate transport in mouse renal tubules. , 1989, Biochimica et biophysica acta.

[28]  R. Gray,et al.  Parabiosis suggests a humoral factor is involved in X‐linked hypophosphatemia in mice , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  H. Tenenhouse,et al.  The renal phosphate transport defect in normal mice parabiosed to X‐linked hypophosphatemic mice persists after parathyroidectomy , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  F. Glorieux,et al.  Defective bone formation by transplanted Hyp mouse bone cells into normal mice. , 1988, Endocrinology.

[31]  M. Fukase,et al.  Hemangiopericytoma-induced osteomalacia: tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity. , 1988, The Journal of clinical endocrinology and metabolism.

[32]  H. Tenenhouse,et al.  Increased renal catabolism of 1,25-dihydroxyvitamin D3 in murine X-linked hypophosphatemic rickets. , 1988, The Journal of clinical investigation.

[33]  L. Hersh,et al.  Evidence for an essential histidine in neutral endopeptidase 24.11. , 1987, Biochemistry.

[34]  Y. Ohshima,et al.  Signals for the selection of a splice site in pre-mRNA. Computer analysis of splice junction sequences and like sequences. , 1987, Journal of molecular biology.

[35]  H. Tenenhouse,et al.  Protein kinase activity and protein kinase inhibitor in mouse kidney: effect of the X-linked Hyp mutation and vitamin D status. , 1985, Endocrinology.

[36]  J. Schwartz,et al.  The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice , 1980, Nature.

[37]  L. Solomon,et al.  Vitamin D-resistant rickets associated with epidermal nevus syndrome: demonstration of a phosphaturic substance in the dermal lesions. , 1977, The Journal of pediatrics.

[38]  W. L. Hawley,et al.  Renal transplantation in hypophosphatemia with vitamin D-resistant rickets. , 1974, Archives of internal medicine.

[39]  C. Carter Mendelian Inheritance in Man , 1967 .

[40]  N. Rawlings,et al.  Evolutionary families of metallopeptidases. , 1995, Methods in enzymology.

[41]  M. Fournié-Zaluski,et al.  Inhibitors of neprilysin: design, pharmacological and clinical applications. , 1995, Methods in enzymology.

[42]  The X-Chromosome Inactivation and the Location and Expression of X-linked Genes , 2022 .